Our Pros Weigh In On Whether Palantir Stock Can Hit $200
This week’s sentiment survey will tell us where our team stands on the stock market before digging in on Tesla, SpaceX, and Palantir. Plus, why your 401(k) may be invested in the wrong things.
Top 6 Stocks On My Shopping List as Market Calls for Strategy Change
It’s time to change strategy as earnings season closes and seasonal weakness creeps in.
It’s Time to Increase Exposure to Micron
Buying Micron is the next best step in the memory and storage trade.
After Rocket Lab Fires Off Solid Earnings, I’m Pulling the Trigger
Let’s dive into the most recent quarterly report and I’ll give my take on the stock now.
Apple CEO Exit Could Lower Revenue Bar After Downgrade
Is outgoing Apple CEO Tim Cook smoothing the path for his successor?
Did Today’s Dull Trading Foreshadow a Rise in Volatility?
Despite the dullness, there were some interesting things to notice. Let’s dig into the NYSE New Lows indicator and more.
Charting Microsoft, Palantir, Amazon, RTX and Potentially Upping 2 Targets
Here’s how I see these four Sarge-folio stocks and why I could increase the price targets on two.
Does an Auction for a Rare Ferrari Say Anything About the Strength of the Economy?
It’s car week! Business leaders and wealthy consumers will be taking over the Monterey Peninsula to share and buy rare cars. What does this market say about the health of the economy?
This Psychedelic Biotech Play Could See a Leg Up After Encouraging LSD Trials
The speculative action is cooling but individual names keep working.
On a High Note: I’m Buying More Alto, Taking Aim at Another Stock
Here’s why I’m buying more Alto Ingredients, and looking to gun it for this stock.